Fungal peritonitis in peritoneal dialysis patients: Successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial

Peritoneal Dialysis International

Volumn 30, Issue 6, 2010, Pages 619-625

  Restrepo, César ^a   Chacon, Jose ^a   Manjarres, Gilberto ^a  

^a UNIVERSIDAD DE CALDAS   (Colombia)

Author keywords

Fluconazole; Fungal peritonitis; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; CEFRADINE; CIPROFLOXACIN; DICLOXACILLIN; FLUCONAZOLE; GENTAMICIN; PSEUDOMONIC ACID;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL PERITONITIS; CANDIDA; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG SAFETY; EXIT SITE INFECTION; FEMALE; FEVER; FUNGAL PERITONITIS; HUMAN; INTERSTITIAL NEPHRITIS; LAPAROSCOPIC SURGERY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PERITONEAL CATHETER; PERITONITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY INFECTION; TUNNEL INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS; CATHETERS, INDWELLING; CHEMOPREVENTION; COINFECTION; FEMALE; FIBROSIS; FLUCONAZOLE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; LAPAROSCOPY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; TISSUE ADHESIONS; YOUNG ADULT;

EID: 78650163643     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2008.00189     Document Type: Article

References (52)

1. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. ISPD Guidelines/Recommendations. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20:828-9]. Perit Dial Int 2000; 20:396-411.
2. Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int 2000; 58:384-9.
3. Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M. Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. Clin Infect Dis 2003; 36:927-31.
4. Ram R, Swarnalatha G, Neela P, Dakshina Murty KV. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre experience in India. Nephron Clin Pract 2008; 110:c207-12.
5. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009, 76:622-8.
6. Das R, Vaux E, Barker L, Naik R. Fungal peritonitis complicating peritoneal dialysis: report of 18 cases and analysis of outcomes. Adv Perit Dial 2006; 22:55-9.
7. Bren A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1998; 17:839-43.
8. Lo WK, Chan TM, Lui SL, Li FK, Cheng IKP. Fungal peritonitis- current status 1998. Perit Dial Int 1999; 19(Suppl 2): S286-90.
9. Restrepo CA. Treatment of bacterial peritonitis with oncedaily dose of intraperitoneally antibiotics. Acta Medica Colombiana 2006; 31:97-103.
10. Fourtounas C, Dousdampanis P, Hardalias A, Vlachojannis JG. Peritoneoscopic reinsertion of a peritoneal dialysis catheter after fungal peritonitis: the advantage of visual information. Perit Dial Int 2009; 29:580-5.
11. Chan TM, Chan CY, Cheng SW, Lo WK, Cheng IK. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9:539-42.
12. Goldie SJ, Troidle LK, Torres C, Brennan NG, Dunne D, Kliger AS, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28:86-91.
13. Michel C, Courdavault L, al Khayat R, Viron B, Roux P, Mignon F. Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994; 14:113-20.
14. Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambulatory peritoneal dialysis-the Auckland experience. Am J Kidney Dis 1992; 20:492-6.
15. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48:96-101.
16. Bordes A, Campos-Herrero MI, Fernandez A, Vega N, Rodriguez JC, Palop L. Predisposing and prognostic factors of fungal peritonitis in peritoneal dialysis. Perit Dial Int 1995; 15:275-6.
17. The Turkish Multicenter Peritoneal Dialysis Study Group (TULIP). The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: experience in Turkey. Perit Dial Int 2000; 20:338-41.
18. Wang AYM, Yu AWY, Li PKT, Lam PKW, Leung CB, Lai KN, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9 year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36:1183-92.
19. Chen CM, Ho MW, Wang JH. Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. J Microbiol Immunol Infect 2004; 37:115-20.
20. Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2005; 25:207-22.
21. Indhumathi E, Chandrasekaran V, Jagadeswaran D, Varadarajan M, Abraham G, Soundararajan P. The risk factors and outcome of fungal peritonitis in continuous ambulatory peritoneal dialysis patients. Indian J Med Microbiol 2009, 27:59-61.
22. Garcia-Martos P, Gil de Sola F, Garcia-Agudo L, Garcia- Agudo R, Tejuca F, Calle L. Fungal peritonitis in continuous ambulatory peritoneal dialysis: a 10 cases description. Nefrologia 2009, 29:534-9.
23. Liu YL, Huang CC, Kao MT. Residual renal function predicts outcome of fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2006; 26:407-9.
24. Choi P, Nemati E, Banerjee A, Preston E, Levy J, Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 2004; 43:103-11.
25. Chan TM, Chan CY, Cheng SW, Lo WK, Lo CY, Cheng IK. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9:539-42.
26. Raaijmakers R, Schroder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 2007; 22:288-93.
27. Boer WH, van Ampting JMA, Vos P. Successful treatment of eight episodes of Candida peritonitis without catheter removal using intracatheter administration of amphotericin B. Perit Dial Int 2007; 27:208-10.
28. Guditi S, Prasad N, Kaligotla VD. Simultaneous catheter removal and reinsertion in fungal peritonitis. Perit Dial Int 2008, 28:675-7.
29. Wong PN, Lo KY, Tong GMW, Chan SF, Lo MW, Mak SK, et al. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis. Perit Dial Int 2008; 28:155-62.
30. Lui SL, Chan TM, Lai KN, Lo WK. Tuberculous and fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 2007; 27(Suppl 2): S263-6.
31. Lye WC. Catheter removal for fungal peritonitis: sooner or later. Perit Dial Int 2008; 28:130-3.
32. Johnson RJ, Ramsey PG, Gallagher N, Ahmad S. Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis. Am J Nephrol 1985; 5:169-75.
33. Oygar DD, Altiparmak MR, Murtezaoglu A, Yalin AS, Ataman R, Serdengecti K. Fungal peritonitis in peritoneal dialysis: risk factors and prognosis. Ren Fail 2009, 31: 25-8.
34. Predari SC, De Paulis AN, Veron D, Zucchini A, Santoianni JE. Fungal peritonitis in patients on peritoneal dialysis: twenty five years of experience in a teaching hospital in Argentina. Rev Argent Microbiol 2007; 39:213-17.
35. Chou CY, Kao MT, Kuo HL, Liu JS, Liu YL, Huang CC. Gramnegative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients. Perit Dial Int 2006; 26:607-8.
36. Toon S, Ross CE, Gokal R, Rowland M. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole. Br J Clin Pharmacol 1990; 29:221-6.
37. Berl T, Wilner KD, Gardner M, Hansen RA, Farmer B, Baris BA, et al. Pharmacokinetics of fluconazole in renal failure. J Am Soc Nephrol 1995; 6:242-7.
38. Cousin L, Berre ML, Vacher VL, Izzedine H, Deray G. Dosing guidelines for fluconazole in patients with renal failure. Nephrol Dial Transplant 2003; 18:2227-31.
39. Debruyne D, Ryckelynck JP, Moulin M, Hurault de Ligny B, Levaltier B, Bigot MC. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis. Clin Pharmacokinet 1990; 18:491-8.
40. Blowey DL, Garg UC, Kearns GL, Warady BA. Peritoneal penetration of amphotericin B complex and fluconazole in a pediatric patient with fungal peritonitis. Adv Perit Dial 1998; 14:247-50.
41. Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991; 17:43-6.
42. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin for candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28:549-52.
43. Williams PF, Moncrieff N, Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20:352-3.
44. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18:583-9.
45. Wong PN, Lo KY, Tong GMW, Chan SF, Lo MW, Mak SK, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27:531-6.
46. Lye WC. Nystatin prophylaxis for fungal peritonitis: to be or not to be? Perit Dial Int 2007; 27:511-13.
47. Robitaille P. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15:77-8.
48. Wadhwa N, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12:189-91.
49. Morey A, Lima C, Matas B, Munar MA. Profilaxis con fluconazol de las peritonitis fúngicas en diálisis peritoneal. Nefrologia 2001; 21:608.
50. Plaza MM, Roman AV, Rodriguez MS, Piñero DF. Ten years without fungal peritonitis: a single center's experience. Perit Dial Int 2007; 27:460-3.
51. Cornely OA, Lasso M, Betts R, Klimko N, Vasquez J, Dobb G, et al. Caspofungin for the treatment of less common forms of invasive candidiasis. J Antimicrob Chemother 2007; 60:363-9.
52. Fourtounas C, Marangos M, Kalliakmani P, Savidaki E, Goumenos DS, Vlachojannis JG. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 2006; 21:236-7.